Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 4Completed 2Suspended 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 5Lymphoma, T-Cell 2Immunoblastic Lymphadenopathy 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Large-Cell, Anaplastic 1GATA2 Deficiency 1Enteropathy-Associated T-Cell Lymphoma 1

Interventions

prednylidene 1deltacortene 1brincidofovir 1Vincristine 1Specimen Handling 1Prednisone 1Magnetic Resonance Spectroscopy 1Lenalidomide 1Etoposide 1Doxorubicin 1Cyclophosphamide 1Biopsy 1Azacitidine 1Abatacept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × Azacitidine × Clear all
NCT07388563 2026-05-08

Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 1 Suspended
20 enrolled
LymphoidOther hematologic neoplasm

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡